Literature DB >> 8465635

Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.

H G Wiener1, G P Vooijs, B van't Hof-Grootenboer.   

Abstract

Two thousand two hundred thirteen smears of urinary specimens from 263 patients with bladder disorders were reviewed and the results correlated with the clinical status at the time of urine collection and with the histologic diagnosis during follow-up. In all cases a cytologic diagnosis of malignancy was histologically confirmed at follow-up, reflecting the high predictive value of a positive result in cytology. Cytologic diagnoses were also analyzed for the interval between the cytologic and histologic diagnosis of malignancy. In cases of cytologic diagnosis of malignancy, at times without a clinical suspicion of severe abnormality, an interval of up to 691 days was registered before a malignant process was confirmed histologically. Furthermore, the influence of tumor grade and mode of therapy on the diagnostic accuracy of urinary cytology was evaluated. The accuracy of urinary cytology differed clearly between untreated and treated patients with both high and low grade tumors. Patients who received surgical therapy, radiotherapy and chemotherapy were grouped into three groups. Accuracy of cytologic diagnosis was calculated in relation to variations in therapy and in tumor grade. Minor differences in accuracy were found between specimens from patients after surgical therapy, chemotherapy and radiotherapy. The data from this study suggest that the diagnostic accuracy of urinary cytology is very much related to the histologic grade of bladder tumors, to pretreatment and posttreatment status, and only minimally to the mode of therapy itself (e.g., radiotherapy, chemotherapy or surgical therapy). The high percentage of cytologic diagnoses of atypia in specimens from patients undergoing chemotherapy and radiotherapy reflects the diagnostic problems.

Entities:  

Mesh:

Year:  1993        PMID: 8465635

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  33 in total

1.  The consequence of delayed fixation on subsequent preservation of urine cells.

Authors:  Hussain G Ahmed; Murtada Am Tom
Journal:  Oman Med J       Date:  2011-01

Review 2.  [Noninvasive and invasive bladder cancer: diagnostics and treatment].

Authors:  P J Goebell; F Vom Dorp; C Rödel; D Frohneberg; J W Thüroff; D Jocham; C Stief; S Roth; R Knüchel; K W Schmidt; I Kausch; D Zaak; C Wiesner; K Miller; R Sauer; H Rübben
Journal:  Urologe A       Date:  2006-07       Impact factor: 0.639

3.  Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.

Authors:  Hyebin Lee; Kwangsoo Kim; Jongmin Woo; Joonho Park; Hyeyoon Kim; Kyung Eun Lee; Hyeyeon Kim; Youngsoo Kim; Kyung Chul Moon; Ji Young Kim; In Ae Park; Bo Bae Shim; Ji Hye Moon; Dohyun Han; Han Suk Ryu
Journal:  Mol Cell Proteomics       Date:  2018-06-27       Impact factor: 5.911

4.  Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.

Authors:  Michelle D Reid; Adeboye O Osunkoya; Momin T Siddiqui; Stephen W Looney
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

5.  Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.

Authors:  Mohit Gupta; Niv Milbar; Giorgia Tema; Filippo Pederzoli; Meera Chappidi; Max Kates; Christopher J VandenBussche; Trinity J Bivalacqua
Journal:  World J Urol       Date:  2019-01-23       Impact factor: 4.226

6.  Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.

Authors:  R Fedriga; R Gunelli; O Nanni; F Bacci; D Amadori; D Calistri
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

7.  UroSEEK gene panel for bladder cancer surveillance.

Authors:  Regan Wong; Charles J Rosser
Journal:  Transl Androl Urol       Date:  2019-12

8.  Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.

Authors:  Murat Lekili; Ercüment Sener; Mehmet Akif Demir; Gökhan Temeltaş; Talha Müezzinoğlu; Coşkun Büyüksu
Journal:  Urol Res       Date:  2003-12-19

9.  Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:  Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Journal:  Rev Urol       Date:  2008

10.  Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.

Authors:  Rou Wang; David S Morris; Scott A Tomlins; Robert J Lonigro; Alexander Tsodikov; Rohit Mehra; Thomas J Giordano; L Priya Kunju; Cheryl T Lee; Alon Z Weizer; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.